Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2009;53:885-892
Published online before print April 27, 2009, doi: 10.1161/HYPERTENSIONAHA.109.130054
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
53/6/885    most recent
HYPERTENSIONAHA.109.130054v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Addabbo, F.
Right arrow Articles by Goligorsky, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Addabbo, F.
Right arrow Articles by Goligorsky, M. S.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Pathophysiology
Right arrow Energy metabolism
Right arrow Oxidant stress
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors

(Hypertension. 2009;53:885.)
© 2009 American Heart Association, Inc.


Brief Review

Mitochondria and Reactive Oxygen Species

Francesco Addabbo; Monica Montagnani; Michael S. Goligorsky

From the Departments of Medicine and Pharmacology (F.A., M.S.G.), Renal Research Institute, New York Medical College, Valhalla; and the Department of Pharmacology and Human Physiology (F.A., M.M.), University of Bari Medical School, Bari, Italy.

Correspondence to Michael S. Goligorsky, Renal Research Unit, Department of Medicine and Pharmacology, New York Medical College, 95 Grasslands Rd, Valhalla, NY 10595. E-mail Michael_goligorsky@nymc.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Fascination by the mitochondria, "the colonial posterity of migrant prokaryocytes, probably primitive bacteria that swam into ancestral precursors of our eukaryotic cells and stayed there,"1 stems from the above-mentioned nebulous endosymbiotic theory of their origin, as well as from the growing realization of a very special role that they play in the pathogenesis of diverse diseases.

These organelles generate energy primarily in the form of the electrochemical proton gradient ({Delta}µH+), which fuels ATP production, ion transport, and metabolism.2 Generation of this universal energy currency, {Delta}µH+, occurs through the series of oxidative reactions conducted by the respiratory chain complexes at the ion-impermeable, almost cholesterol-free inner membrane. Reduced nicotinamide adenine dinucleotide represents the entry point to the complex I (reduced nicotinamide adenine dinucleotide:ubiquinone reductase), whereas the reduced ubiquinol enters the respiratory chain in the complex III (ubiquinol:cytochrome c [cyt-c] reductase) to reduce cyt-c, the electron carrier to the complex IV, cyt-c oxidase. Each of these steps generates {Delta}µH+ by electrogenic pumping of protons from the mitochondrial matrix to the intermembrane space and is coupled to electron flow, thus generating the electric membrane potential of –180 to –220 mV and a pH gradient of 0.4 to 0.6 U across the inner mitochondrial membrane resulting in the negatively charged matrix side of the membrane and alkaline matrix. Ultimately, accumulated {Delta}µH+ is converted into the influx of protons into the matrix driving ATP synthesis or protein transport. In addition, these end points are necessary for the execution of 2 major enzymatic metabolic pathways within . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. A. Potenza, F. Addabbo, and M. Montagnani
Vascular actions of insulin with implications for endothelial dysfunction
Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E568 - E577.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Li, Y. Liu, Z. Li, L. Yang, S. Wang, and M.-X. Guan
Failures in Mitochondrial tRNAMet and tRNAGln Metabolism Caused by the Novel 4401A>G Mutation Are Involved in Essential Hypertension in a Han Chinese Family
Hypertension, August 1, 2009; 54(2): 329 - 337.
[Abstract] [Full Text] [PDF]